|
1
|
Iwanami J, Mogi M, Tsukuda K, Jing F,
Ohshima K, Wang XL, Nakaoka H, Kan-no H, Chisaka T, Bai HY, et al:
Possible synergistic effect of direct angiotensin II type 2
receptor stimulation by compound 21 with memantine on prevention of
cognitive decline in type 2 diabetic mice. Eur J Pharmacol.
724:9–15. 2014. View Article : Google Scholar
|
|
2
|
Hishikawa N, Yamashita T, Deguchi K, Wada
J, Shikata K, Makino H and Abe K: Cognitive and affective functions
in diabetic patients associated with diabetes-related factors,
white matter abnormality and aging. Eur J Neurol. 22:313–321. 2015.
View Article : Google Scholar
|
|
3
|
Wang YB, Wang S, Bai R, Du JL, Xing Q, Ba
Y, Yang Y, Zhang XY, Shi CH and Yao JJ: Efficacy of switching from
premixed insulin to insulin glargine regimen in Type 2 diabetes
mellitus patients with different islet functions. Mol Med Rep.
10:1096–1102. 2014.PubMed/NCBI
|
|
4
|
Lian G, Yue X, Xianxiang Z, Yong L,
Weijuan L and Bing C: Insulinization: A promising strategy for the
treatment of type 2 diabetes mellitus. Exp Ther Med. 6:1300–1306.
2013.PubMed/NCBI
|
|
5
|
Mossello E, Ballini E, Boncinelli M,
Monami M, Lonetto G, Mello AM, Tarantini F, Baldasseroni S,
Mannucci E and Marchionni N: Glucagon-like peptide-1, diabetes, and
cognitive decline: Possible pathophysiological links and
therapeutic opportunities. Exp Diabetes Res. 2011:2816742011.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Marder TJ, Flores VL, Bolo NR, Hoogenboom
WS, Simonson DC, Jacobson AM, Foote SE, Shenton ME, Sperling RA and
Musen G: Task-induced brain activity patterns in type 2 diabetes: A
potential biomarker for cognitive decline. Diabetes. 63:3112–3119.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Liu B, Kuang L and Liu J: Bariatric
surgery relieves type 2 diabetes and modulates inflammatory factors
and coronary endothelium eNOS/iNOS expression in db/db mice. Can J
Physiol Pharmacol. 92:70–77. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhu KX, Nie SP, Li C, Gong D and Xie MY:
Ganoderma atrum polysaccharide improves aortic relaxation in
diabetic rats via PI3K/Akt pathway. Carbohydr Polym. 103:520–527.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Jia D, Heng LJ, Yang RH and Gao GD: Fish
oil improves learning impairments of diabetic rats by blocking
PI3K/AKT/nuclear factor-κB-mediated inflammatory pathways.
Neuroscience. 258:228–237. 2014. View Article : Google Scholar
|
|
10
|
Lin X, Chen X, Ye J, Li Q, Zhou J, Wu X,
Huang Y, Li X, Shi Y, Li S, Li L and Cai H: Association between
endogenous secretory receptor for advanced glycation-end products
(esRAGE) and carotid intima-media thickness in type 2 diabetes. Exp
Clin Endocrinol Diabetes. 122:277–280. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Si X, Li P, Zhang Y, Zhang Y, Lv W and Qi
D: Renoprotective effects of olmesartan medoxomil on diabetic
nephropathy in streptozotocin-induced diabetes in rats. Biomed Rep.
2:24–28. 2014.PubMed/NCBI
|
|
12
|
Pietzsch J, Laube M, Bechmann N, Pietzsch
FJ and Kniess T: Protective effects of 2,3-diaryl-substituted
indole-based cyclooxygenase-2 inhibitors on oxidative modification
of human low density lipoproteins in vitro. Clin Hemorheol
Microcirc. Dec 29–2014.Epub ahead of print. PubMed/NCBI
|
|
13
|
Price TO, Eranki V, Banks WA, Ercal N and
Shah GN: Topiramate treatment protects blood-brain barrier
pericytes from hyperglycemia-induced oxidative damage in diabetic
mice. Endocrinology. 153:362–372. 2012. View Article : Google Scholar :
|
|
14
|
Liu Y, Tian X, Gou L, Sun L, Ling X and
Yin X: Luteolin attenuates diabetes-associated cognitive decline in
rats. Brain Res Bull. 94:23–29. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Stinghen AE, Massy ZA, Vlassara H, Striker
GE and Boullier A: Uremic Toxicity of Advanced Glycation End
Products in CKD. J Am Soc Nephrol. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Jiao L, Stolzenberg-Solomon R, Zimmerman
TP, Duan Z, Chen L, Kahle L, Risch A, Subar AF, Cross AJ,
Hollenbeck A, et al: Dietary consumption of advanced glycation end
products and pancreatic cancer in the prospective NIH-AARP Diet and
Health Study. Am J Clin Nutr. 101:126–134. 2015. View Article : Google Scholar
|
|
17
|
Chang CS, Chang CL and Lai GH: Reactive
oxygen species scavenging activities in a chemiluminescence model
and neuroprotection in rat pheochromocytoma cells by astaxanthin,
beta-carotene, and canthaxanthin. Kaohsiung J Med Sci. 29:412–421.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Visser H, van Ooyen AJ and Verdoes JC:
Metabolic engineering of the astaxanthin-biosynthetic pathway of
Xanthophyllomyces dendrorhous. FEMS Yeast Res. 4:221–231. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wu H, Niu H, Shao A, Wu C, Dixon BJ, Zhang
J, Yang S and Wang Y: Astaxanthin as a Potential Neuroprotective
Agent for Neurological Diseases. Mar Drugs. 13:5750–5766. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Rao AR, Sindhuja HN, Dharmesh SM, Sankar
KU, Sarada R and Ravishankar GA: Effective inhibition of skin
cancer, tyrosinase, and antioxidative properties by astaxanthin and
astaxanthin esters from the green alga Haematococcus pluvialis. J
Agric Food Chem. 61:3842–3851. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chan KC, Pen PJ and Yin MC:
Anticoagulatory and antiinflammatory effects of astaxanthin in
diabetic rats. J Food Sci. 77:H76–H80. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lee DH, Kim CS and Lee YJ: Astaxanthin
protects against MPTP/MPP+-induced mitochondrial
dysfunction and ROS production in vivo and in vitro. Food Chem
Toxicol. 49:271–280. 2011. View Article : Google Scholar
|
|
23
|
Sun K, Chang X, Yin L, Li J, Zhou T, Zhang
C and Chen X: Expression and DNA methylation status of microRNA-375
in patients with type 2 diabetes mellitus. Mol Med Rep. 9:967–972.
2014.
|
|
24
|
Petty MA and Lo EH: Junctional complexes
of the blood-brain barrier. Permeability changes in
neuroinflammation. 68:311–323. 2002.
|
|
25
|
Biessels GJ, Deary IJ and Ryan CM:
Cognition and diabetes: A lifespan perspective. Lancet Neurol.
7:184–190. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Naito Y, Uchiyama K, Aoi W, Hasegawa G,
Nakamura N, Yoshida N, Maoka T, Takahashi J and Yoshikawa T:
Prevention of diabetic nephropathy by treatment with astaxanthin in
diabetic db/db mice. Biofactors. 20:49–59. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Bulhak AA, Jung C, Ostenson CG, Lundberg
JO, Sjöquist PO and Pernow J: PPAR-alpha activation protects the
type 2 diabetic myocardium against ischemia-reperfusion injury:
Involvement of the PI3-Kinase/Akt and NO pathway. Am J Physiol
Heart Circ Physiol. 296:H719–H727. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
You JJ, Yang CH, Yang CM and Chen MS:
Cyr61 induces the expression of monocyte chemoattractant protein-1
via the integrin αvβ3, FAK, PI3K/Akt and NF-κB pathways in retinal
vascular endothelial cells. Cell Signal. 26:133–140. 2014.
View Article : Google Scholar
|
|
29
|
Cho YR, Lim JH, Kim MY, Kim TW, Hong BY,
Kim YS, Chang YS, Kim HW and Park CW: Therapeutic effects of
fenofibrate on diabetic peripheral neuropathy by improving
endothelial and neural survival in db/db mice. PLoS One.
9:e832042014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Malemud CJ: The PI3K/Akt/PTEN/mTOR
pathway: a fruitful target for inducing cell death in rheumatoid
arthritis? Future Med Chem. 7:1137–1147. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wang T, Mao X, Li H, Qiao S, Xu A, Wang J,
Lei S, Liu Z, Ng KF, Wong GT, et al: N-Acetylcysteine and
allopurinol up-regulated the Jak/STAT3 and PI3K/Akt pathways via
adiponectin and attenuated myocardial postischemic injury in
diabetes. Free Radic Biol Med. 63:291–303. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Li Z, Dong X, Liu H, Chen X, Shi H, Fan Y,
Hou D and Zhang X: Astaxanthin protects ARPE-19 cells from
oxidative stress via upregulation of Nrf2-regulated phase II
enzymes through activation of PI3K/Akt. Mol Vis. 19:1656–1666.
2013.PubMed/NCBI
|
|
33
|
Kavitha K, Kowshik J, Kishore TK, Baba AB
and Nagini S: Astaxanthin inhibits NF-κB and Wnt/β-catenin
signaling pathways via inactivation of Erk/MAPK and PI3K/Akt to
induce intrinsic apoptosis in a hamster model of oral cancer.
Biochim Biophys Acta. 1830.4433–4444. 2013.
|
|
34
|
Zhang XS, Zhang X, Wu Q, Li W, Zhang QR,
Wang CX, Zhou XM, Li H, Shi JX and Zhou ML: Astaxanthin alleviates
early brain injury following subarachnoid hemorrhage in rats:
Possible involvement of Akt/bad signaling. Mar Drugs. 12:4291–4310.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Liu YW, Zhu X, Yang QQ, Lu Q, Wang JY, Li
HP, Wei YQ, Yin JL and Yin XX: Suppression of methylglyoxal
hyperactivity by mangiferin can prevent diabetes-associated
cognitive decline in rats. Psychopharmacology (Berl). 228:585–594.
2013. View Article : Google Scholar
|
|
36
|
Wu W, Wang X, Xiang Q, Meng X, Peng Y, Du
N, Liu Z, Sun Q, Wang C and Liu X: Astaxanthin alleviates brain
aging in rats by attenuating oxidative stress and increasing BDNF
levels. Food Funct. 5:158–166. 2014. View Article : Google Scholar
|
|
37
|
Augusti PR, Conterato GM, Somacal S,
Sobieski R, Quatrin A, Maurer L, Rocha MP, Denardin IT and
Emanuelli T: Astaxanthin reduces oxidative stress, but not aortic
damage in atherosclerotic rabbits. J Cardiovasc Pharmacol Ther.
14:314–322. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Choi SK, Park YS, Choi DK and Chang HI:
Effects of astaxanthin on the production of NO and the expression
of COX-2 and iNOS in LPS-stimulated BV2 microglial cells. J
Microbiol Biotechnol. 18:1990–1996. 2008.
|
|
39
|
Lee SJ, Bai SK, Lee KS, Namkoong S, Na HJ,
Ha KS, Han JA, Yim SV, Chang K, Kwon YG, et al: Astaxanthin
inhibits nitric oxide production and inflammatory gene expression
by suppressing I (kappa)B kinase-dependent NF-kappaB activation.
Mol Cells. 16:97–105. 2003.PubMed/NCBI
|
|
40
|
Song X, Wang B, Lin S, Jing L, Mao C, Xu
P, Lv C, Liu W and Zuo J: Astaxanthin inhibits apoptosis in
alveolar epithelial cells type II in vivo and in vitro through the
ROS-dependent mitochondrial signalling pathway. J Cell Mol Med.
18:2198–2212. 2014. View Article : Google Scholar : PubMed/NCBI
|
